Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

In Silico Liabilities Task Force

In Silico Liabilities Task Force

BACK

In Silico Liabilities Task Force

Mission: Investigate and document the liabilities and responsibilities for software and modeler developer of in silico solutions

Many organizations are hesitant before investing massively in the promising
in silico approach:

  • It is widely believed that this technology could improve, and potentially save, the lives of many people by providing additional information to decision-makers.
  • It is also recognized that no model is perfect and that sometimes non-optimal decisions can be made.

This Task Force intends to answer the most frequently asked questions:

  • Who would be responsible in this situation?
  • Where are the liabilities?
  • What should in silico technology providers do to demonstrate that they have done everything possible to maximize patient safety while providing digital evidence to decision makers?

Although we began these activities in 2023 and are still seeking a co-chair, we achieved our first deliverables by identifying several SMEs among our members and compiling an initial collection of existing literature. We have started working on an evergreen internal position paper to compile our existing knowledge, resources, and expertise to provide initial assistance and guidance to our members.

Our future activities will focus on a continued exploration and accumulation of existing literature, but also joining forces to engage with external experts and local authorities.

Goals

  • Compile and review existing legal texts related to this topic.
  • Provide PRELIMINARY guidance for software and model developers by sharing and explaining existing documents.
  • Create a SMEs group among our members.
  • Identify key stakeholders including specialized lawyers (EU – US).

Thierry Marchal

Thierry Marchal

Avicenna Alliance Secretary General

Program Director for Healthcare Solution, ANSYS, Inc.

SEND E-MAIL
READ BIO

NEWS

News The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

On April 10, the European Parliament overwhelmingly backed the reform of General Pharmaceutical Legislation (GPL), marking a pivotal moment in healthcare regulation. With a resounding majority, both the Directive and Regulation were embraced, reflecting a collaborative effort within the ENVI committee.

News The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

Tox by Design is a prominent European toxicological expertise firm specializing in conducting toxicological Risk Assessments (RAs) for various industries such as biotech, pharmaceuticals, cosmetics, medical devices, and API synthesis.

News Marc Horner is the new Avicenna International Affairs Working Group Leader

Marc Horner is the new Avicenna International Affairs Working Group Leader

We are thrilled to announce that Marc Horner, Distinguished Engineer at Ansys, and Global Harmonization Task Force leader at the Avicenna Alliance, has been appointed as the new International Affairs Working Group Leader. Marc was already acting as a close partner of Nathalie Virag, former head of the International Affairs Working Group, recently appointed by Medtronic to prestigious responsibilities.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry